85 filings
6-K
MDXH
MDxHealth SA
5 Jun 24
Report of Foreign Private Issuer
5:02pm
6-K
MDXH
MDxHealth SA
16 May 24
Report of Foreign Private Issuer
8:14am
6-K
MDXH
MDxHealth SA
6 May 24
Report of Foreign Private Issuer
8:00am
6-K
MDXH
MDxHealth SA
1 May 24
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed
4:03pm
6-K
MDXH
MDxHealth SA
1 May 24
Unaudited Condensed Consolidated Statement of Profit or Loss
8:54am
424B5
5hrl3 0enw27t3
30 Apr 24
Prospectus supplement for primary offering
5:20pm
6-K
ki1 fmu5c99
12 Mar 24
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering
5:01pm
6-K
bcskmaq3s9rm0qu 6kw
6 Mar 24
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results
5:04pm
6-K
gs1je6 frrvr
16 Feb 24
Mdxhealth Announces Resignation of Board Member
4:05pm
6-K
80u53mt
8 Jan 24
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues
4:39pm
6-K
xh4vylw
19 Dec 23
MDxHealth Announces Completion of Transition to Single Listing on Nasdaq
4:25pm
6-K
jd9iaug1tjof7 e3hu
27 Nov 23
MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq
4:01pm
8-A12B/A
4686p6kvghp6e0j7k vq
24 Nov 23
Registration of securities on exchange (amended)
1:25pm
25-NSE
u8wmin88o1cghooj844t
24 Nov 23
Exchange delisting
1:24pm
6-K
qfzajm5
15 Nov 23
Report of Foreign Private Issuer
4:01pm
6-K
3xa4eoq94fjuq86777k
13 Nov 23
MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights
5:06pm
6-K
0bmowmvp5khnz4 prb1u
8 Nov 23
Report of Foreign Private Issuer
4:23pm
6-K
mbaei tvv
8 Nov 23
Report of Foreign Private Issuer
4:01pm
6-K
zm5skn
6 Nov 23
Report of Foreign Private Issuer
8:00am